Skip to main content

Coronavirus Studies in Nonhuman Primate Models

This page provides a curated list of coronavirus studies and reviews using nonhuman primate (NHP) models.

Coronavirus Investigated: SARS-CoV-2
NHP Species:
Year Published: 2022
Study Type/Review: vaccine
NPRC/Institute: Shionogi & Co., Ltd., Biopharmaceutical Research Division, Osaka, Japan
Keywords: SARS-CoV-2, recombinant spike protein vaccine, virus variants, immune response
Summary of Study: Homologous and heterologous booster vaccinations of S-268019-b, a recombinant S protein-based vaccine
References: doi: 10.1016/j.vaccine.2022.10.092
Contact Info: Shinya Omoto: [email protected]
URL: https://www.sciencedirect.com/science/article/pii/S0264410X22013792?via%3Dihub
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review:
NPRC/Institute: Chinese Academy of Medical Sciences
Keywords: SARS-CoV-2, proteomic and phosphoproteomic profiling, lung and liver pathology, primates
Summary of Study: Proteomic and phosphoproteomic profiling of SARS-CoV-2-infected lung and liver tissues showed potentially active protein synthesis and processing, and dysregulated ECM, cell-to-cell junction, and cytoskeleton but no fibrosis in both the infected lung and liver.
References: PMID: 35091530 / doi: 10.1038/s41392-022-00882-7
Contact Info: Shaui-Yao Lu: [email protected]
URL: https://www.nature.com/articles/s41392-022-00882-7
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review: vaccine
NPRC/Institute: Institute of Biological Products; Chinese Academy of Medicine Sciences & Peking Union Medical College
Keywords: SARS-CoV-2, recombinant protein subunit vaccine and an inactivated vaccine, virus variants, primates
Summary of Study: Both vaccines evaluated in this study significantly reduced the viral load in the respiratory tract, alleviated pathological changes, and relieved lung inflammation in vaccinated macaques. The possible contribution of antibodies possessing neutralizing reactivity or cell-mediated cytotoxicity and immune memory to vaccine induced protection was also highlighted.
References: PMID: 35241645 / doi: 10.1038/s41392-022-00926-y
Contact Info: Junzhi Wang: [email protected]
URL: https://www.nature.com/articles/s41392-022-00926-y
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review: vaccine
NPRC/Institute: Tulane National Primate Research Center
Keywords: SARS-CoV-2, noncompeting antibody cocktail, vaccine, immune response, primates
Summary of Study: A neutralizing mAB cocktail with extended half-life can be delivered intramuscularly to provide prophylactic protection against infection in rhesus macaques.
References: PMID: 35291730 / doi: 10.1016/j.medj.2022.02.004
Contact Info: Jay Rappaport: [email protected]
URL: https://www.cell.com/med/fulltext/S2666-6340(22)00087-3?_returnURL=https%3A%2F%…
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review: vaccine
NPRC/Institute: Bavarian Nordic GmbH; Biomedical Primate Research Centre; Aarhus University; University of Copenhagen; AdaptVac Aps
Keywords: SARS-CoV-2, capsid virus-like particle-based vaccine ABNCoV2, immunogenicity, primates
Summary of Study: ABNCoV2 induced strong and long-lasting neutralizing antibody responses and efficacy against SARS-CoV-2 in NHP.
References: PMID: 35479095 / doi: 10.3389/fimmu.2022.857440
Contact Info: Ariane Volkmann: [email protected]
URL: https://www.frontiersin.org/articles/10.3389/fimmu.2022.857440/full
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review:
NPRC/Institute: Biomedical Primate Research Centre (BPRC), Rijswijk, Netherlands; Department of Radiology and Nuclear Medicine, Tracer Center Amsterdam (TCA), Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands
Keywords: SARS-CoV-2, PET-CT imaging, lungs, inflammation, primates
Summary of Study: Vaccine candidate involving a valuable radiotracer to visualize SARS-CoV-2-associated pulmonary inflammation
References: PMID: 35660200 PMCID: PMC9148436 DOI: 10.1016/j.nucmedbio.2022.05.002
Contact Info: Marieke A Stammes: [email protected]
URL: https://www.sciencedirect.com/science/article/pii/S0969805122020509?via%3Dihub
Coronavirus Investigated: SARS-CoV-2
NHP Species: marmosets
Year Published: 2022
Study Type/Review:
NPRC/Institute: Defence Science and Technology Laboratory; United Kingdom Health and Security Agency
Keywords: SARS-CoV-2, aerosolized virus, pathology, immune response, primates
Summary of Study: Following COVID-19 exposure, marmosets did not develop clinical signs other than a disruption to the diurnal temperature rhythm. This may be due to an innate immunological response, which included an increase in neutrophils and monocytes and a reduction in T-cells.
References: PMID: 35891560 / doi: 10.3390/v14071580
Contact Info: Rachel Ireland: [email protected]
URL: https://www.mdpi.com/1999-4915/14/7/1580
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review:
NPRC/Institute: University of Veterinary and Animal Sciences, Pakistan
Keywords: SARS-CoV-2, iodine complexes, treatment, primates
Summary of Study: Iodine complexes have antiviral activity and help to clear coronavirus from monkeys, and Renessans with iodine complexes and ascorbic acid may provide an additive option for treatment.
References: PMID: 36143459; doi: 10.3390/life12091424
Contact Info: Tahir Yaqub: [email protected]
URL: https://www.mdpi.com/2075-1729/12/9/1424
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review:
NPRC/Institute: Duke University School of Medicine, Durham, NC; California National Primate Research Center; others.
Keywords: SARS-CoV-2, age-dependent responses, immune response, pathology, primates
Summary of Study: Age-dependent responses to SARS-CoV-2 in dam/infant pairs
References: doi: 10.4049/immunohorizons.2200075
Contact Info: Maria Blasi: [email protected]
URL: https://journals.aai.org/immunohorizons/article/6/12/851/237621/Dam-Infant-Rhes…
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review: prevention
NPRC/Institute: AstraZeneca; BIOQUAL; Vanderbilt University; USAMRIID
Keywords: SARS-CoV-2, monoclonal antibody combination, AZD7442,virus protection, humans, primates
Summary of Study: AZD7442, a monoclonal antibody comprised of AZD8895 and AZD1061, demonstrated potent in vitro neutralization against SARS-CoV-2 VOCs, in vivo efficacy in both prevention and treatment settings of SARS-CoV-2 infection in NHPs, and extended half-life in NHPs and healthy adult participants.
References: PMID: 35076282 / doi: 10.1126/scitranslmed.abl8124
Contact Info: Mark Esser: [email protected]
URL: https://www.science.org/doi/10.1126/scitranslmed.abl8124?url_ver=Z39.88-2003&rf…
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review:
NPRC/Institute: Northwestern University; Tulane National Primate Research Center; NIAID; Sanford Burnham Prebys Medical Discovery Institute; Bioqual; New Iberia Research Center
Keywords: SARS-CoV-2, antibody-based in vivo probe system, lungs, primates
Summary of Study: Results provide proof of concept for the use of in vivo antibody-based probes to study SARS-CoV-2 infection dynamics in rhesus macaques.
References: PMID: 35003140 / doi: 10.3389/fimmu.2021.810047
Contact Info: Thomas Hope: [email protected]
URL: https://www.frontiersin.org/articles/10.3389/fimmu.2021.810047/full
Coronavirus Investigated: SARS-CoV-2
NHP Species:
Year Published: 2022
Study Type/Review: vaccine
NPRC/Institute: Beth Israel Deaconess Medical Center; Ragon Institution of MGH, MIT, and Harvard; Bioqual; Washington University School of Medicine; Emory School of Medicine, Tufts University Cummings School of Veterinary Medicine
Keywords: SARS-CoV-2, mRNA-based BNT162b2 vaccine, virus variants, immune response, primates
Summary of Study: BNT162b2 and Ad26.COV2.S provided robust protection against high-dose challenge with the SARS-CoV-2 Omicron variant in macaques. Protection against this highly mutated SARS-CoV-2 variant correlated with both humoral and cellular immune responses.
References: PMID: 35169798 / doi: 10.1101/2022.02.06.479285
Contact Info: Dan Barouch: [email protected]
URL: https://www.biorxiv.org/content/10.1101/2022.02.06.479285v1
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review: vaccine
NPRC/Institute: NIAID; Yerkes National Primate Research Center; Emory School of Medicine; Bioqual; Modernal; Harvard T.H. Chan School of Public Health
Keywords: SARS-CoV-2, vaccination, mRNA-1273 or mRNA-Omicron boost, pathology, primates
Summary of Study: Boosting with homologous mRNA-1273 or mRNA-Omicron leads to comparable and significant increases in neutralizing antibody responses against all VOC, including Omicron.
References: PMID: 35447072 / doi: 10.1016/j.cell.2022.03.038
Contact Info: Daniel Douek: [email protected]; Robert Seder: [email protected]
URL: https://www.cell.com/cell/fulltext/S0092-8674(22)00388-9?_returnURL=https%3A%2F…
Coronavirus Investigated: SARS-CoV-2
NHP Species: marmosets
Year Published: 2022
Study Type/Review:
NPRC/Institute: Universidade Federal Rural do Rio de Janeiro; Universidade Federal do Mato Grosso; Universidade Federal do Parana
Keywords: SARS-CoV-2, natural infections, free-ranging animals, pathology, primates
Summary of Study: Free-ranging non-human primates are potential hosts for natural SARS-CoV-2 infection.
References: PMID: 35577455 / doi: 10.1016/j.jcpa.2022.03.005
Contact Info: Valeria Dutra: [email protected]
URL: https://www.sciencedirect.com/science/article/pii/S0021997522000433?via%3Dihub
Coronavirus Investigated: SARS-CoV-2
NHP Species:
Year Published: 2022
Study Type/Review: vaccine
NPRC/Institute: Shionogi & Co., Ltd.; Department of Pathology and Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan
Keywords: SARS-CoV-2, recombinant S-protein vaccine S-268019-b, immune response, primates
Summary of Study: Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys
References: PMID: 35691872 PMCID: PMC9167832 DOI: 10.1016/j.vaccine.22.05.081
Contact Info: Hideki Hasegawa: [email protected]
URL: https://www.sciencedirect.com/science/article/pii/S0264410X22007186?via%3Dihub
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review: vaccine
NPRC/Institute: ReNAP Therapeutics; Mashhad Medical Technologies Science Park; Mashhad University of Medical Sciences; Alzahra University; Tehran University of Medical Sciences; Shahid Beheshti University of Medical Sciences;
Keywords: SARS-CoV-2, mRNA-vaccine, COReNAPCIN®, immune response, mice, primates
Summary of Study: COReNAPCIN is a nucleoside modified mRNA-based vaccine that creates a strong humoral response and protects from symptomatic SARS-CoV-2 infection and clinical damage, thus making it a potent vaccine candidate.
References: PMID: 36056015 / doi: 10.1038/s41541-022-00528-3
Contact Info: Somaye Dehghanizadeh: [email protected]
URL: https://www.nature.com/articles/s41541-022-00528-3
Coronavirus Investigated: SARS-CoV-2
NHP Species: african green monkeys
Year Published: 2022
Study Type/Review:
NPRC/Institute: Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi India
Keywords: SARS-CoV-2, virus variants, geographical distribution, genome sequencing, several animal species, primates
Summary of Study: Mutations and evolution of seven distinct clades in non?human hosts
References: doi: 10.1111/zph.12971
Contact Info: Thenmalarchelvi Rathinavelan: [email protected]
URL: https://onlinelibrary.wiley.com/doi/full/10.1111/zph.12971
Coronavirus Investigated: SARS-CoV-2
NHP Species:
Year Published: 2022
Study Type/Review:
NPRC/Institute: Keio University School of Medicine, Tokyo, Japan; RIKEN Center for Integrative Medical Sciences, Infectious Diseases Research unit, Kanagawa, Japan, numerous others.
Keywords: SARS-CoV-2, therapeutic neutralizing antibodies, virus variants, immune response, hamsters, primates
Summary of Study: Potent SARS-CoV-2 neutralizing antibodies with therapeutic effects
References: doi: 10.1016/j.isci.2022.105596
Contact Info: Masaru Takeshita: [email protected]
URL: https://www.sciencedirect.com/science/article/pii/S2589004222018685?via%3Dihub
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review:
NPRC/Institute: MIT; Broad Institute of MIT and Harvard; Ragan Institute of MGH, MIT, and Harvard; University of Duisburg-Essen; Space Exploration Technologies Corp.; Harvard University; Vanderbilt University Medical Center; Northwestern University Feinberg School of Medicine; University of Bonn; Howard Hughes Medical Institute; Massachusetts Consortium on Pathogen Readiness; Harvard Medical School; Brigham and Womoen's Hospital; Harvard Humanitarian Initiative
Keywords: SARS-CoV-2, immune biomarkers, reinfection, immune response, primates
Summary of Study: A specific set of SARS-CoV-2-specific humoral features, including spike RBD-specific IgG1 titers, nucleocapsid-specific IgG3 titers, and anti-spike RBD FcyR2A binding activity, were identified as robust biomarkers of reinfection that translate across species. When reinfection cannot be confirmed by viral sequence, changes in SARS-CoV-2 humoral immune responses may offer inexpensive, reliable, and effective measures to track reinfection.
References: PMID: 35073738 / doi: 10.1128/mbio.02141-21
Contact Info: Douglas Lauffenburger: [email protected]; Galit Alter: [email protected]
URL: https://journals.asm.org/doi/full/10.1128/mbio.02141-21?rfr_dat=cr_pub++0pubmed…
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review:
NPRC/Institute: Chinese Academy of Sciences; China Agricultural University; Capital Medical University; University of Science & Technology of China; Chinese Academy of Medical Sciences and Peking Union Medical College; Chinese Center for Disease Control and Prevention
Keywords: SARS-CoV-2, human neutralizing antibodies, virus variants, mice, primates
Summary of Study: bsAB15 was developed and shown to efficiently neutralize all single-mAb escape mutants. This bsAb is a feasible and effective strategy to treat and prevent severe COVID-19.
References: PMID: 35228696 / doi: 10.1038/s41590-022-01138-w
Contact Info: Yan Wu: [email protected]; Feng Gao: [email protected]
URL: https://www.nature.com/articles/s41590-022-01138-w
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review:
NPRC/Institute: NIAID; University of California, San Diego; University of Cape Town, Observatory, South Africa
Keywords: SARS-CoV-2, mild infection, pathology, immune response, primates
Summary of Study: SARS-CoV-2 replication wanes in the lungs, as well as the nasal and oral mucosa, of rhesus macaques before antigen-specific effector T cells arrive at those sites, suggesting that innate immunity efficiently restricts viral replication during mild COVID-19.
References: PMID: 35271298 / doi: 10.1126/sciimmunol.abo0535
Contact Info: Daniel Barber: [email protected]
URL: https://www.science.org/doi/full/10.1126/sciimmunol.abo0535?rfr_dat=cr_pub++0pu…
Coronavirus Investigated: SARS-CoV-2
NHP Species: african green monkeys, rhesus macaques
Year Published: 2022
Study Type/Review:
NPRC/Institute: Tulane University School of Medicine; Tulane National Primate Research Center
Keywords: SARS-CoV-2, neuropathogenesis, primates
Summary of Study: Substantial pathological changes in brains of SARS-CoV-2 infected NHPs are compatible with autopsy and imaging reports of infected human subjects.
References: PMID: 35365631 / doi: 10.1038/s41467-022-29440-z
Contact Info: Tracy Fischer: [email protected]
URL: https://www.nature.com/articles/s41467-022-29440-z
Coronavirus Investigated: SARS-CoV-2
NHP Species:
Year Published: 2022
Study Type/Review: vaccine
NPRC/Institute: Center for Genetic Engineering and Biotechnology, CIGB, Ave. 31 E/158 y 190, Havana 10600, Cuba
Keywords: SARS-CoV-2, chimeric antigen vaccine, immune response, mice, primates
Summary of Study: Fusion of SARS-CoV-2 receptor binding domain with the extracellular domain of human CD154 is a promising vaccine candidate
References: PMID: 35746505 PMCID: PMC9228316 DOI: 10.3390/vaccines10060897
Contact Info: Yamila Carpio and Mario Pablo Estrada: [email protected]; [email protected]
URL: https://www.mdpi.com/2076-393X/10/6/897
Coronavirus Investigated: SARS-CoV-2
NHP Species: marmosets
Year Published: 2022
Study Type/Review: vaccine
NPRC/Institute: Meissa Vaccines Inc; Bill & Melinda Gates Foundation; BIOQUAL Inc; Butler University; Vanderbilt University School of Medicine; University of Texas Medical Branch
Keywords: SARS-CoV-2, attenuated recombinant vaccine, immune response, primates
Summary of Study: A live, attenuated, recombinant human respiratory virus that expresses a chimeric SARS-CoV-2 spike protected against challenge and induced immunoglobulin and neutralizing antibodies.
References: PMID: 35906244 / doi: 10.1038/s41541-022-00509-6
Contact Info: Mariana F. Tioni: [email protected]
URL: https://www.nature.com/articles/s41541-022-00509-6
Coronavirus Investigated: SARS-CoV-2
NHP Species: multiple species
Year Published: 2022
Study Type/Review:
NPRC/Institute: Gujarat Biotechnology Research Centre (GBRC), India; Kamdhenu University, Gujarat, India; University of California Santa Barbara, Santa Barbara, CA.
Keywords: SARS-CoV-2, surveillance, RT-PCR, several animal species, primates
Summary of Study: Highlights transmission of SARS-CoV-2 infection from human to animals and suggests being watchful for zoonosis.
References: doi: 10.3390/ijerph192114391
Contact Info: Arunkumar Patel: [email protected]
URL: https://www.mdpi.com/1660-4601/19/21/14391
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques, african green monkeys
Year Published: 2022
Study Type/Review:
NPRC/Institute: Tulane National Primate Research Center; Tulane School of Medicine
Keywords: SARS-CoV-2, aerosol or intra-tracheal/intra-nasal infection, viral load, inflammation, primates
Summary of Study: Cellular mechanisms underlying acute respiratory distress syndrome
References: doi: 10.1038/s42003-022-04310-y
Contact Info: Namita Rout: [email protected]
URL: https://www.nature.com/articles/s42003-022-04310-y
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review: vaccine
NPRC/Institute: Shanghai Medical College, Fudan University; Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College; the First Affiliated Hospital of Guangzhou Medical University; Guangzhou Eighth People's Hospital of Guangzhou Medical University; Bio-Island; Graduate School of Peking Union Medical College; NIFDC; Fulgent Pharma LLC
Keywords: SARS-CoV-2, pan-sarbecovirus vaccines, STING agonist CF501, virus variants, immune response, mice, rabbits, primates.
Summary of Study: A pan-sarbecovirus vaccine was designed by using human IgG Fc-conjugated RBD from the original SARS-CoV-2 strain as the vaccine's immunogen and the STING agonist CF501 as the vaccine's adjuvant. This CF501/RBD-Fc vaccine candidate was able to induce extremely potent, durable, and broad-spectrum nAb and T cell responses, as well as protective immunity, suggesting its potential for development as a highly potent and durable pan-sarbecovirus vaccine.
References: PMID: 35046518 / doi: 10.1038/s41422-022-00612-2
Contact Info: Youchun Wang: [email protected]; Yilong Zhang: [email protected]; Jincun Zhao: [email protected]
URL: https://www.nature.com/articles/s41422-022-00612-2
Coronavirus Investigated: SARS-CoV-2
NHP Species: pigtail macaques
Year Published: 2022
Study Type/Review: vaccine
NPRC/Institute: University of Washington; Washington National Primate Research Center; HDT Bio
Keywords: SARS-CoV-2, immunocompromised animals, SIV, RNA vaccine, immunogenicity, primates
Summary of Study: SARS-CoV-2 alphavirus-derived replicon RNA vaccine formulated with a novel Lipid InOrganic Nanoparticle (LION) emulsion (repRNA-CoV2S) induced robust cellular and humoral immune responses after a single immunization in immunocompromised SIV-infected animals as a highly relevant model of untreated HIV infection in humans.
References: PMID: 34992610 / doi: 10.3389/fimmu.2021.800723
Contact Info: Deborah Fuller: [email protected]
URL: https://www.frontiersin.org/articles/10.3389/fimmu.2021.800723/full
Coronavirus Investigated: SARS-CoV-2
NHP Species:
Year Published: 2022
Study Type/Review: diagnostics
NPRC/Institute: Universite Paris-Saclay, Inserm, CEA; Sorbonne Universite; BioPredictive; Institut Pasteur
Keywords: SARS-CoV-2, blood test, diagnostics, primates
Summary of Study: Results validate the diagnostic and prognostic performances of A1HPV6 in patients infected by SARS-CoV-2, not hospitalized in ICU. These results are reinforced by similar kinetics of A1, HP, and A2M observed in the macaque model.
References: PMID: 35174366 / doi: 10.1016/j.gastha.2021.12.009
Contact Info: Thierry Poynard: [email protected]
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818442/
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review:
NPRC/Institute: California National Primate Research Center; University of California, Davis; Vitalant Research Institute; University of Colorado School of Medicine; University of California, Irvine; University of California, San Francisco
Keywords: SARS-CoV-2, human convalescent plasma, inflammation, primates
Summary of Study: Administration of CCP had minimal effects on reducing virus replication in the respiratory tract, but it significantly reduced lung inflammation. These data, combined with the results of monoclonal antibody studies, emphasize the need to use products with high titers of neutralizing antibodies, and guide the future development of antibody-based therapies.
References: PMID: 35443018 / doi: 10.1371/journal.ppat.1009925
Contact Info: Koen Van Rompay: [email protected]; Michael Busch: [email protected]; Rachel Reader: [email protected]
URL: https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009925
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review:
NPRC/Institute: Chinese Academy of Medical Sciences and Peking Union Medical College
Keywords: SARS-CoV-2, longitudinal analyses, lungs, intestines, immune response, primates
Summary of Study: Findings indicate an imbalance of immune dynamic in intestinal mucosa during SARS-CoV-2 infection, which may underlie ongoing rectal viral shedding and mild tissue damage.
References: PMID: 35594870 / doi: 10.1016/j.celrep.2022.110864
Contact Info: Zhanlong He: [email protected]; Haijing Shi: [email protected]; Qihan Li: [email protected]; Longing Liu: [email protected]
URL: https://www.cell.com/cell-reports/fulltext/S2211-1247(22)00637-4?_returnURL=htt…
Coronavirus Investigated: SARS-CoV-2
NHP Species:
Year Published: 2022
Study Type/Review:
NPRC/Institute: CAS Key Laboratory of Computational Biology; Shanghai Institute of Nutrition and Health; University of Chinese Academy of Sciences; Chinese Academy of Sciences; Max Planck Institute of Psychiatry, Proteomics and Biomarkers
Keywords: SARS-CoV-2, circadian gene networks, transcriptome, primates
Summary of Study: Many mammalian genes are controlled by a central clock under circadian control, resulting in a rhythmic expression of genes involved in homeostasis. SARS-CoV-2 related genes are also rhythmically expressed, suggesting close interactions with circadian regulators.
References: PMID: 35906476 / doi: 10.1038/s42003-022-03722-0
Contact Info: Guang-Zhong Wang: [email protected]
URL: https://www.nature.com/articles/s42003-022-03722-0
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review: vaccine
NPRC/Institute: National Institutes for Food and Drug Control, Beijing; Guangzhou Laboratory; Kunming National High-level Biosafety Primate Research Center
Keywords: SARS-CoV-2, vaccine, chimpanzee adenovirus vector, immune response, mice, primates
Summary of Study: Using a chimpanzee adenovirus vectored vaccine expressing SARS-CoV2 spike in combination with an inactivated vaccine reduced lung injury risk while maintaining flexibility of the antibody regulation system.
References: PMID: 36059554 / doi: 10.3389/fimmu.2022.949248
Contact Info: Junzhi Wang: [email protected]; Zhenglun Liang: [email protected]; Miao Xu: [email protected]
URL: https://www.frontiersin.org/articles/10.3389/fimmu.2022.949248/full
Coronavirus Investigated: SARS-CoV-2
NHP Species: african green monkeys
Year Published: 2022
Study Type/Review: vaccine
NPRC/Institute: North Carolina State University; University of North Carolina at Chapel Hill
Keywords: SARS-CoV-2, dry powder mRNA vaccine, tissue distribution, mice, primates
Summary of Study: Room-temperature stable inhalable lung-derived exosomes have been developed as mRNA and protein drug carriers, and they are deliverable to the lungs by dry powder inhalation and result in a greater immunoglobulin response compared to the standard.
References: PMID: 35847197 / doi: 10.1016/j.matt.2022.06.012
Contact Info: Ke Cheng: [email protected]
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272513/
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review: pathogenesis
NPRC/Institute: California National Primate Research Center; University of California, Davis
Keywords: SARS-CoV-2, neurotropism, microglia, astrocytes, inflammation, aging, primates
Summary of Study: SARS-CoV-2 infects neurons and induces neuroinflammation
References: doi: 10.1016/j.celrep.2022.111573
Contact Info: John H. Morrison: [email protected]
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554328/#:~:text=Seven%20days%20af…
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review: vaccine
NPRC/Institute: University of Oxford, UK; Ifakara Health Institute, Bagamoyo, Tanzania
Keywords: SARS-CoV-2, review, long-lived plasma cells, lymph node germinal centers, humans, primates
Summary of Study: Human lymphoid tissue sampling for vaccinology
References: doi: 10.3389/fimmu.2022.1045529
Contact Info: Carolyn M. Nielsen: [email protected]
URL: https://www.frontiersin.org/articles/10.3389/fimmu.2022.1045529/full
Coronavirus Investigated: SARS-CoV-2
NHP Species: african green monkeys
Year Published: 2022
Study Type/Review: vaccine
NPRC/Institute: City of Hope National Medical Center
Keywords: SARS-CoV-2, synthetic multiantigen modified vaccine, COH04S1, immune response, hamsters, primates
Summary of Study: Vaccine candidate C0H04S1 stimulates protective immunity against SARS-CoV-2 in Syrian hamsters by intramuscular and intranasal vaccination and in non-human primates through two-dose and single-dose regimens.
References: PMID: 35064109 / doi: 10.1038/s41541-022-00436-6
Contact Info: Felix Wussow: [email protected]
URL: https://www.nature.com/articles/s41541-022-00436-6
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review: vaccine
NPRC/Institute: Chinese Academy of Sciences & Peking Union Medical College; National Institute for Viral Disease Control and Prevention
Keywords: SARS-CoV-2, inactivated vaccine, pathology, virus variants, primates
Summary of Study: Three doses of a prototypic SARS-CoV-2 inactivated vaccine reduced viral loads in nasal, throat and anal swabs and pulmonary tissues and improved the pathological changes lungs of animals infected by variants of Alpha, Beta and Delta.
References: PMID: 35217639 / doi: 10.1038/s41392-022-00920-4
Contact Info: Zhongping Xie: [email protected]; Wenjie Tan: [email protected]
URL: https://www.nature.com/articles/s41392-022-00920-4
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review:
NPRC/Institute: Tulane National Primate Research Center; Michigan Technological University; Tulane University
Keywords: SARS-CoV-2, renin-angiotensin system, HIV co-infection, gene expression, primates
Summary of Study: Findings suggest a possible impact of SIV/HIV infection on expression of ACE2 and RAS-associated proteins resulting in the loss of gut homeostasis.
References: PMID: 35281029 / doi: 10.3389/fimmu.2022.835686
Contact Info: Bapi Pahar: [email protected]
URL: https://www.frontiersin.org/articles/10.3389/fimmu.2022.835686/full
Coronavirus Investigated: SARS-CoV-2
NHP Species:
Year Published: 2022
Study Type/Review:
NPRC/Institute: Université Paris-Saclay; Assistance Publique-Hôpitaux de Paris; Obesity Center, Department of Digestive, Oncologic and Metabolic Surgery, Institut Mutualiste Montsouris, Paris
Keywords: SARS-CoV-2, fat tissue, diagnostics, immunity, primates
Summary of Study: Subcutaneous adipose tissue (SCAT) is selectively infected by SARS-CoV-2 although changes in the immune properties of adispose tissue are observed in both SCAT and visceral adipose tissue
References: PMID: 35661814 PMCID: PMC9166782 DOI: 10.1038/s42003-022-03503-9
Contact Info: Christine Bourgeois: [email protected]
URL: https://www.nature.com/articles/s42003-022-03503-9
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review:
NPRC/Institute: Wuhan Institute of Virology; Chinese Academy of Science; Wuhan National Biosafety Library, others
Keywords: SARS-CoV-2, testicular pathological damage, inflammation, primates
Summary of Study: SARS-CoV-2 infection induces testicular injury in Rhesus macaque
References: 10.1016/j.virs.2022.10.008
Contact Info: Z. Wuan: [email protected]
URL: https://www.sciencedirect.com/science/article/pii/S1995820X22001833?via%3Dihub
Coronavirus Investigated: SARS-CoV-2
NHP Species:
Year Published: 2022
Study Type/Review: vaccine
NPRC/Institute: Emergent BioSolutions; Yoh Services LLC; Sanofi Pasteur; Translate Bio; UT Health Science Center at Houston
Keywords: SARS-CoV-2, virus variants, vaccine, boost, neutralizing effects, primates
Summary of Study: This study showed that a third vaccination administered as a booster, regardless of composition, to the currently approved two dose regimens could effectively promote broadly neutralizing antibodies against all variants of concern.
References: PMID: 35101265 / doi: 10.1016/j.vaccine.2022.01.021
Contact Info: Natalie Anosova: [email protected]
URL: https://www.sciencedirect.com/science/article/pii/S0264410X22000457?via%3Dihub
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review: vaccine
NPRC/Institute: China Pharmaceutical University; Yunnan Walvax Biotech
Keywords: SARS-CoV-2, chimpanzee adenovirus-based vaccine, immunogenicity, toxicology, rats, primates
Summary of Study: AdC68-19S, a recombinant chimpanzee adenovirus serotype 68 vector-based vaccine encoding the full-length spike protein of SARS-CoV-2, induced an effective immune response with a good safety profile in rhesus macaques.
References: PMID: 35226134 / doi: 10.1007/s00204-021-03221-x
Contact Info: Zhen Huang: [email protected]
URL: https://link.springer.com/article/10.1007/s00204-021-03221-x
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review: vaccine
NPRC/Institute: Beijing Institute of Microbiology and Epidemiology; Sinocelltech, Ltd.; Chinese Academy of Medical Sciences
Keywords: SARS-CoV-2, polysaccharide–protein-conjugated nanoparticle vaccine, virus variants, mice, rats, primates
Summary of Study: A novel nanoparticle vaccine was designed and prepared by chemically conjugating recombinant SARD-CoV-2 RBD and PPS14. Studies have demonstrated that SCTV01B vaccination induced potent and broad neutralizing antibodies and cellular immune responses against SARS-CoV-2 in mice, rats, and nonhuman primates, as well as high OPA against S. pneumoniae serotype 14.
References: PMID: 35332581 / doi: 10.1002/adma.202200443
Contact Info: Liangzhi Xie: [email protected]
URL: https://onlinelibrary.wiley.com/doi/10.1002/adma.202200443
Coronavirus Investigated: SARS-CoV-2
NHP Species: rhesus macaques
Year Published: 2022
Study Type/Review: vaccine
NPRC/Institute: Peking Union Medical College; National Center of Technology Innovation for Animal Model; Chinese Academy of Sciences; Capital Medical University
Keywords: SARS-CoV-2, inactivated vaccine, booster, immune response, virus variants, primates
Summary of Study: Animals administered with an indicated booster dose and subsequently challenged with Delta or Omicron variants showed markedly reduced viral loads and improved histopathological profiles compared to control animals, indicating that sequential immunization could protect primates against Omicron.
References: PMID: 35436986 / doi: 10.1038/s41392-022-00979-z
Contact Info: Chuan Qin: [email protected];
URL: https://www.nature.com/articles/s41392-022-00979-z
Coronavirus Investigated: SARS-CoV-2
NHP Species:
Year Published: 2022
Study Type/Review: vaccine
NPRC/Institute: Sun Yat-sen University; The First Affiliated Hospital of Guangzhou Medical University; Southern University of Science and Technology; The First Affiliated Hospital of Sun Yat-sen University; Guangdong Provincial Center for Disease Control and Prevention; Guangdong-Hong Kong Joint Laboratory for RNA Medicine
Keywords: SARS-CoV-2, quadrivalent mosaic HexaPro-bearing nanoparticle vaccine, virus variants, mice and primates
Summary of Study: A quadrivalent mosaic nanoparticle vaccine displaying spike proteins from the SARS-CoV-2 prototype and 3 different VOCs elicits equivalent or superior neutralizing antibodies against variant strains in mice and non-human primates with only small reduction in neutralization titers against the ancestral strain.
References: PMID: 35562337 / doi: 10.1038/s41467-022-30222-w
Contact Info: Jin-Cun Zhao: [email protected]; Run-Yu Yuan: [email protected]; Mu-Sheng Zeng: [email protected]
URL: https://www.nature.com/articles/s41467-022-30222-w
Coronavirus Investigated: SARS-CoV-2
NHP Species:
Year Published: 2022
Study Type/Review: vaccine
NPRC/Institute: Affinivax; Ragon Institute of MGH, MIT, and Harvard; Boston Children's Hospital
Keywords: SARS-CoV-2, multiple antigen-presenting system vaccine, pathology, primates
Summary of Study: Multiple Antigen-Presenting System is a novel way to create a vaccine presenting proteins on a polymer and is able to induce antibody formation and reduce viral load in NHPS.
References: PMID: 35891233 / doi: 10.3390/vaccines10071069
Contact Info: Gilles Besin: [email protected]
URL: https://www.mdpi.com/2076-393X/10/7/1069
Coronavirus Investigated: SARS-CoV-2
NHP Species: pigtail macaques, rhesus macaques
Year Published: 2022
Study Type/Review: vaccine
NPRC/Institute: University of Washington; Stanford University School of Medicine; University of Louisiana at Lafayette; Washington University School of Medicine
Keywords: SARS-CoV-2, vaccine, immune response, mice, primates
Summary of Study: Non-human primates and humans are better models than mice when looking at the potency of neutralizing antibody responses from vaccine as their immune and caution should be used when generalizing data from mouse models.
References: PMID: 35988541 / doi: 10.1016/j.celrep.2022.111299
Contact Info: David Veesler: [email protected]
URL: https://www.sciencedirect.com/science/article/pii/S2211124722011196?via%3Dihub
Coronavirus Investigated: SARS-CoV-2
NHP Species: marmosets
Year Published: 2022
Study Type/Review: vaccine
NPRC/Institute: National Research Centre for Epidemiology and Microbiology; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences; Sechenov First Moscow State Medical University
Keywords: SARS-CoV-2, vector-based heterologous vaccine, immune response, mice, primates
Summary of Study: Intranasal Sputnik V vaccine is a novel mucosal vaccine with immunogenic and protective properties identified by immunoglobin and neutralizing antibody production, antigen-specific T-cell response, and cytokine release.
References: PMID: 36031930 / doi: 10.1080/22221751.2022.2119169
Contact Info: Amir I. Tukhvatulin: [email protected]
URL: https://www.tandfonline.com/doi/full/10.1080/22221751.2022.2119169
Coronavirus Investigated: SARS-CoV-2
NHP Species:
Year Published: 2022
Study Type/Review:
NPRC/Institute: National Biodefense Analysis and Countermeasures Center; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health; Censeo Insight, Seattle, Washington, USA.
Keywords: SARS-CoV-2, dose–response relationships, aerosol, virus isolates, primates
Summary of Study: Provides dose response data important to inform disease transmission and hazard modeling
References: doi: 10.1089/jamp.2022.0043
Contact Info: Paul Dabisch: [email protected]
URL: https://www.liebertpub.com/doi/10.1089/jamp.2022.0043